Venous stents are mesh tubes made from alloy which are deployed in the veins to provide them with structural support. They can be of a variety of design and sizes. Stents are delivered to their target area using a vascular catheter in a compressed state. Stents are usually self-expanding, but some require assistance of an inflated balloon.
Most stents once placed do not move easily and can be very difficult to remove when needed. Furthermore, stents can be designed to deliver medications as well slowly over time. As compared to arterial stents, venous stents are designed with more radial strength as there is less blood pressure along the venous system. Additionally, venous stents are more elastic as veins contract and dilate more than arteries.
Stents are used to treat diseases where there is a partial or complete reduction in the blood flow area. Some common diseases that can need venous stents include, post-thrombotic syndrome (PTS), pelvic congestion syndrome (PCS), may-thurner’s syndrome (MTS) and peripheral artery disease (PAD).
Stenting is proven to be safe and successful, therefore it has become more prevalent in the past decades. One key benefit of stenting is that it can be inserted using a catheter without any need for an invasive surgery. Additional benefits of venous stents include: less recovery time; shorter procedure durations and minimal risk of complication.
Based on technology, the venous stents market is bifurcated into illiac vein stent technology and wallstent technology. Wallstents have been the most common stent type available since a very long time. More than 50% of the patients get wallstents in the United States.
Based on application, the venous stents market is fragmented into legs, chest, abdomen, and others. Key factors that made leg segment the frontrunner is the increasing prevalence of Deep Vein Thrombosis.
Based on disease, the venous stents market is fragmented into chronic deep vein thrombosis, post thrombotic syndrome, and others. Key factor increasing the occurrence of chronic deep vein thrombosis is the increasing geriatric population.
For a better understanding of the market adoption of the Venous Stents Market, the market is analysed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World.
Some of the major players operating in the market include Boston Scientific Corporation, Medtronic Plc, Becton, Dickinson and Company, Medica Germany GMBH & Co. KG, Cook Medical, W. L. Gore & Associates, Inc., Cordis, Jotec GmBH, Abbott Laboratories, Optimed Medizinische Instrumente GmBH. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.
TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Objective of the Study
1.4. Stake Holders
1.5. Currency Used in Report
1.6. Scope of the Venous Stents Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Methodology for the Venous Stents Market
2.1.1. Main Objective of the Venous Stents Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 COVID-19 IMPACT
6 MARKET INSIGHTS BY TECHNOLOGY
6.1. Iliac Vein Stent Technology
6.2. Wallstent Technology
7 MARKET INSIGHTS BY APPLICATION
8 MARKET INSIGHTS BY DISEASE
8.1. Chronic Deep Vein Thrombosis
8.2. Post Thrombotic Syndrome
9 MARKET INSIGHTS BY REGION
9.1. NORTH AMERICA VENOUS STENTS MARKET
9.1.1. United States of America
9.1.3. Rest of North America
9.2 EUROPE VENOUS STENTS MARKET
9.2.1. United Kingdom
9.2.6. Rest of Europe
9.3. ASIA-PACIFIC VENOUS STENTS MARKET
9.3.5. Rest of Asia-Pacific
9.4. REST OF THE WORLD VENOUS STENTS MARKET
10 LEGAL AND REGULATORY FRAMEWORK
11 DEMAND AND SUPPLY SIDE ANALYSIS
11.1. Demand Side Analysis
11.2. Supply Side Analysis
11.2.1. Top Product Launches
11.2.2. Top Business Partnerships
11.2.3. Top Business Expansions, Investments and Divestitures
11.2.4. Top Merger and Acquisitions
12 VALUE CHAIN ANALYSIS
13 VENOUS STENTS MARKET TRENDS & INSIGHTS
14 VENOUS STENTS MARKET DYNAMICS
14.3. Impact Analysis
15 COMPETITIVE SCENARIO
15.1. Venous Stents Market Share, by Company 2020
16 COMPANY PROFILED
16.1. Boston Scientific Corporation
16.2. Medtronic Plc
16.3. Becton, Dickinson and Company
16.4. Medica Germany GMBH & Co. KG
16.5. Cook Medical
16.6. W. L. Gore & Associates, Inc.
16.8. Jotec GmBH
16.9. Abbott Laboratories
16.10. Optimed Medizinische Instrumente GmBH
17 DISCLAIMER —-
+44 203 500 2763
+1 62 825 80070
Note: The Heraldkeeper News Department was not involved in the creation of this content.
If you have any problem with this press release? Contact the source provider Heraldkeeper.com, you can contact them here.